Navigation Links
ConjuGon raises $3.3 million to fund clinical trials

Madison, Wis.- ConjuGon, Inc., a privately-held biopharmaceutical company, has raised $3.3 million in an investment round led by Rosetta Partners, a private investment firm based in Lake Forest, Ill.

The Madison-based ConjuGon will use the capital for clinical trials of its treatment for the infections of large wounds, and to fund the developme......

Full article >>> ">Centocor.

Alicia Loffler, director of the Kellogg Center for Biotechnology at Northwestern University.

Tom Rolfs, a member of the Wisconsin Investment Partners and a partner of Red Top Capital.

Carl Spalding, pas......

Full article >>>
'"/>

Source:wistechnology.com By WTN 12/13/06


Related biology technology :

1. ConjuGon gets $730K to treat infections
2. ConjuGon lands $1 million angel investment
3. ConjuGon receives $500,000 to battle bacteria
4. ConjuGon to present at Sachs-Bloomberg Global Biotech Forum
5. ConjuGon Awarded $250,000
6. TomoTherapy raises $223 million in IPO
7. Fusion 2007: CA chief says IT complexity raises risk
8. Inline intellectual property raises legal issues
9. Biotech with Madison ties raises $21M in capital
10. Nerites raises $1 million to improve medical tech
11. Brady Corp. raises $137 million in public offering
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):